CClinicalTrials.gg
WithdrawnNCT06668870Updated Apr 2, 2026

Electronic Health Record-Integrated Patient-Generated Data

An interventional study of Supplemental Text Messaging and Education and Training for Patient-Generated Data in Sepsis, sponsored by Wake Forest University Health Sciences. Withdrawn. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-02.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Supportive care

Why this study was withdrawn
protocol changes were made and study no longer a clinical trial
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to find out if patients that receive supportive messaging with response adaptation are more likely to adhere to patient-generated data collection and electronic health record integration, compared to patients that do not receive supportive messaging.

Read the detailed description

This project will directly inform re-usable strategies to support the integration of important patient-generated data (PGD) into the electronic health record to improve clinical care and research. For this application, investigators propose to develop and test the PGD translational science innovation in patients recovering from sepsis. This diverse patient population frequently suffers from long-term complications that are ideally suited for development and demonstration of strategies to collect, integrate, and examine PGD and builds directly on the study team's robust research portfolio on improving sepsis recovery.

02

Conditions studied

  • Sepsis

Browse trials for

Keywords

  • patient-generated data collection
  • electronic health record monitoring
  • transitional care
03

In context

Sepsis

1,899 studies on the registry are indexed under Sepsis; 462 are open to participants now.

Browse Sepsis studies →

Lead sponsor

Wake Forest University Health Sciences is the lead sponsor of 1,320 studies on the registry; 199 are open to participants now.

Of its 323 completed or terminated interventional studies of FDA-regulated products, 243 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Discharged alive from the hospital without hospice care who meet clinical criteria for infection and organ dysfunction consistent with sepsis
  • Enrolled into the Sepsis Transition and Recovery program
  • Enrolled or willing to enroll as an Epic MyChart user

Exclusion criteria

Exclusion Criteria:

  • Discharged from the hospital with hospice care
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Supportive Messaging

    Supportive messaging is a behavioral intervention delivered to motivate patients to engage with targeted patient-generated data collection tools. Participants will be asked to complete patient-generated data. At baseline, all patients will receive education about the collection of patient-generated data, training in using the data collection tools, and guidance on the standard frequency for collection and sharing of information. At baseline and regular intervals throughout follow up, the supportive messaging arm will receive added text messaging to engage patients and deliver personalized reminders to complete monitoring tasks.

    Behavioral: Supplemental Text Messaging

  • Active comparator
    No Supportive Messaging

    Participants will be asked to complete patient-generated data. At baseline, participants will receive education about the collection of patient-generated data, training in using the data collection tools, and guidance on the standard frequency for collection and sharing of information. Participants will not receive added text messaging to engage patients and deliver personalized reminders to complete monitoring tasks.

    Behavioral: Education and Training for Patient-Generated Data

Interventions

  • BehavioralSupplemental Text Messaging

    Will receive education about the collection of patient-generated data, training in using the data collection tools, and guidance on the standard frequency for collection and sharing of information. Supplemental text messages will be sent to engage patients and deliver personalized reminders to complete monitoring tasks.

  • BehavioralEducation and Training for Patient-Generated Data

    Will receive education about the collection of patient-generated data, training in using the data collection tools, and guidance on the standard frequency for collection and sharing of information.

06

What researchers measure

Primary outcomes

  1. Proportion of Completed Versus Requested Patient-Generated Data

    Patient generated data completion defined as the proportion of completed vs requested patient generated data elements.

    Time frame: 90 days post hospital discharge

Secondary outcomes

  1. Number of Readmissions

    Number of readmissions to inpatient or observation status due to any cause assessed via electronic health record.

    Time frame: 90 days post hospital discharge

  2. Number of Deaths

    Number of participant deaths due to any cause, assessed via electronic health record and national data sources integrated in the enterprise data warehouse.

    Time frame: 90 days post hospital discharge

  3. Number of Emergency Department Visits

    Number of Emergency Department visits assessed via electronic health record.

    Time frame: 90 days post hospital discharge

  4. Number of Outpatient Clinic Visits

    Number of outpatient clinic visits assessed via electronic health record

    Time frame: 90 days post hospital discharge

  5. Number of Hospital-Free Days

    Number of hospital-free days calculated by total of days alive minus days hospitalized, measured from electronic health record data.

    Time frame: 90 days post hospital discharge

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in this article, after deidentification will be shared (text, tables, figures, and appendices).

Supporting information: Study protocol, Sap, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06668870
Lead sponsor
Wake Forest University Health Sciences
Collaborators
National Center for Advancing Translational Sciences (NCATS)
Responsible party
Sponsor
First posted
Nov 1, 2024
Start date
Apr 2026 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Apr 2, 2026

Study contacts

Marc Kowalkowski, PhD
principal investigator · Atrium Health Wake Forest Baptist

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion